AEN’s dnaJP1 Positive Results on Rheumatoid Arthritis’ Treatment. AEN, X-Treme Hot Stock Alert by DrStockPick.com
Source: http://drstockpick.com/?p=4754Posted on Friday, November 13th, 2009 | In Investing Lessons, Stocks to Watch
Dr Stock Pick HOT News & Alerts!
_______________________________________
FREE Daily Stock Alerts From DrStockPick.com
_______________________________________
Friday November 13, 2009
DrStockPick.com Stock Report!
**************************************************************
AEN, Adeona Pharmaceuticals, Inc.
AEN is a specialty pharmaceutical company dedicated to the awareness, diagnosis, prevention and treatment of zinc deficiency and chronic copper toxicity in the mature population. Using AEN’s proprietary, modified oral zinc delivery technologies, AEN is preparing to initiate the first clinical trial of oral zinc therapy for the once-a-day dietary management of Alzheimer’s disease and mild cognitive impairment. AEN is also developing a number of late-stage clinical drug candidates for the treatment of rheumatoid arthritis and multiple sclerosis.
AEN’s Oral dnaJP1 is an orally active epitope-specific immunotherapeutic molecule derived from a family of heat shock proteins that contribute to autoimmune inflammation in rheumatoid arthritis patients.
A Study results of a 160-patient, six-month, double-blind, placebo-controlled Phase 2 clinical trial using AEN’s dnaJP1 for the treatment of rheumatoid arthritis shows Positive Results and holds promise for patients with this disease.
AEN is actively seeking worldwide corporate partners interested in assisting in the further development and commercialization of this novel and potentially important new therapeutic approach for rheumatoid arthritis.
More about AEN at www.adeonapharma.com
AEN, X-Treme Hot Stock Alert by DrStockPick.com
***********Advertisement***********
******************************
Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. (read more) . Rule 17B requires disclosure of payment for investor relations.
Last 5 posts by Dr. Stock Pick
- CSRH, Consorteum Holdings Inc. Announces Settlement of an Outstanding Investment Loan - January 12th, 2010
- DrStockPick.com Stock Report! Most Active Stocks Tuesday Jan. 12, 2010 - January 12th, 2010
- CRWE, Crown Equity Holdings, Inc., A Breakthrough in the Online Media Advertising/Awareness Market - January 12th, 2010
- DrStockPick.com Stock Report! 01/12/10, UNP, WMT, TAXS, LCC, PKE, PCH - January 12th, 2010
- CSRH, Consorteum Holdings Inc. Aims to Increase Revenues - CSRH will focus on Adding New Recurring Revenue Streams for Transaction Processing and Card Issuance Activities - January 12th, 2010
 About Dr. Stock Pick (http://drstockpick.com)
Dr. Stock Pick is a seasoned equity trader and financial investor well known for his savvy business instincts. He’s on the Crown Equity Holdings, Inc (CRWE.OB) financial staff as a professional investment analyst and consultant. He’s syndicated on over 1000 websites including crwenews.com, stock-ir.com giving daily up to the minute information about stocks, options, currencies and more. Be sure to sign up for his award winning newsletter featuring his top stock alerts. |
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.